S. Galatius

1.7k total citations · 1 hit paper
18 papers, 1.1k citations indexed

About

S. Galatius is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, S. Galatius has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 10 papers in Surgery and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in S. Galatius's work include Coronary Interventions and Diagnostics (10 papers), Acute Myocardial Infarction Research (7 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). S. Galatius is often cited by papers focused on Coronary Interventions and Diagnostics (10 papers), Acute Myocardial Infarction Research (7 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). S. Galatius collaborates with scholars based in Denmark, Switzerland and Italy. S. Galatius's co-authors include Jan Kyst Madsen, Anders Hvelplund, Steen Z. Abildstrøm, Eva Prescott, Flemming Pedersen, Lasse Jespersen, Erik Jørgensen, Henning Kelbæk, Franz R. Eberli and Matthias Pfisterer and has published in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

S. Galatius

16 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events

2011 602 citations Lasse Jespersen, Anders Hvelplund et al. European Heart Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Galatius Denmark	10	838	566	550	97	44	18	1.1k
Vivian G. Ng United States	15	582 0.7×	229 0.4×	359 0.7×	180 1.9×	72 1.6×	50	863
Sang Hoon Lee South Korea	20	746 0.9×	468 0.8×	644 1.2×	147 1.5×	26 0.6×	70	961
Bent Raungaard Denmark	13	837 1.0×	549 1.0×	826 1.5×	91 0.9×	71 1.6×	55	1.1k
Bas L. van der Hoeven Netherlands	15	659 0.8×	426 0.8×	478 0.9×	90 0.9×	33 0.8×	30	922
Wanlin Yeh United States	13	819 1.0×	509 0.9×	841 1.5×	179 1.8×	46 1.0×	21	1.1k
Ton de Vries Netherlands	19	1.1k 1.3×	784 1.4×	1.2k 2.2×	325 3.4×	37 0.8×	35	1.6k
Yukio Nishida Japan	10	549 0.7×	371 0.7×	492 0.9×	99 1.0×	51 1.2×	16	784
Masahiro Natsuaki Japan	20	907 1.1×	215 0.4×	729 1.3×	179 1.8×	16 0.4×	81	1.2k
Michael Magro Netherlands	18	941 1.1×	584 1.0×	873 1.6×	195 2.0×	33 0.8×	50	1.3k
Michele Roesle United States	17	748 0.9×	571 1.0×	1.1k 1.9×	259 2.7×	94 2.1×	58	1.4k

Countries citing papers authored by S. Galatius

Since Specialization

Citations

This map shows the geographic impact of S. Galatius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Galatius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Galatius more than expected).

Fields of papers citing papers by S. Galatius

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Galatius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Galatius. The network helps show where S. Galatius may publish in the future.

Co-authorship network of co-authors of S. Galatius

This figure shows the co-authorship network connecting the top 25 collaborators of S. Galatius. A scholar is included among the top collaborators of S. Galatius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Galatius. S. Galatius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Møgelvang, Rasmus, S. Galatius, Sune Pedersen, et al.. (2021). Left ventricular end-diastolic pressure is associated with left atrial functional measures by echocardiography. European Heart Journal - Cardiovascular Imaging. 22(Supplement_1).

Giustino, Gennaro, Usman Baber, Philippe Généreux, et al.. (2016). TCT-288 Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Intervention: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaborative Patient-Level Pooled Analysis. Journal of the American College of Cardiology. 68(18). B118–B119.

Biering‐Sørensen, Tor, Kotaro Nochioka, Kim Wadt Hansen, et al.. (2016). TCT-312 Increased Cardiac Death and Stent Thrombosis in Chronic Obstructive Pulmonary Disease Patients Undergoing Percutaneous Coronary Intervention. An analysis of the BASKET-PROVE I and II trials. Journal of the American College of Cardiology. 68(18). B129–B129. 1 indexed citations

Ferko, Nicole, Giuseppe Ferrante, Ireena M. Soleas, et al.. (2016). Cost‐effectiveness of percutaneous coronary intervention with cobalt‐chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta‐analysis of randomized trials. Catheterization and Cardiovascular Interventions. 89(6). 994–1002. 5 indexed citations

Vassalli, Giuseppe, Catherine Klersy, Stefano De Servi, et al.. (2015). Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial. American Heart Journal. 173. 1–7. 2 indexed citations

Kurz, David J., Alain Bernheim, David Tüller, et al.. (2015). Improved outcomes of elderly patients treated with drug-eluting versus bare metal stents in large coronary arteries: Results from the BAsel Stent Kosten-Effektivitäts Trial PROspective Validation Examination randomized trial. American Heart Journal. 170(4). 787–795.e1. 10 indexed citations

Valgimigli, Marco, Manel Sabaté, Salvatore Brugaletta, et al.. (2014). Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis. BMJ. 349(nov04 12). g6427–g6427. 50 indexed citations

Pfisterer, Matthias, Anders Hvelplund, Stefano De Servi, et al.. (2013). Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease. International Journal of Cardiology. 168(3). 2381–2388. 10 indexed citations

Biering‐Sørensen, Tor, Stefan Hoffmann, Rasmus Møgelvang, et al.. (2013). Myocardial strain analysis by 2-dimensional speckle tracking echocardiography improves diagnostics of coronary artery stenosis in stable angina pectoris. European Heart Journal. 34(suppl 1). P3988–P3988. 11 indexed citations

10.

Møgelvang, Rasmus, Sune Ammentorp Haahr-Pedersen, Mette Bjerre, et al.. (2012). Osteoprotegerin improves risk detection by traditional cardiovascular risk factors and hsCRP. Heart. 99(2). 106–110. 29 indexed citations

11.

Jespersen, Lasse, Anders Hvelplund, Steen Z. Abildstrøm, et al.. (2011). Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. European Heart Journal. 33(6). 734–744. 602 indexed citations breakdown →

12.

Iversen, Allan, S. Galatius, Ulrik Abildgaard, et al.. (2011). Intracoronary Compared to Intravenous Abciximab in Patients with ST Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention Reduces Mortality, Target Vessel Revascularization and Reinfarction after 1 Year. Cardiology. 120(1). 43–49. 7 indexed citations

13.

Iversen, Allan, S. Galatius, Sune Pedersen, Jan Kyst Madsen, & Jan Skov Jensen. (2011). Impact of Abciximab in Elderly Patients with High-Risk Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Drugs & Aging. 28(5). 369–378. 1 indexed citations

14.

Kaiser, Christoph, S. Galatius, Paul Erné, et al.. (2010). Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries. New England Journal of Medicine. 363(24). 2310–2319. 171 indexed citations

15.

Hoffmann, Stefan, Rasmus Møgelvang, Niels Thue Olsen, et al.. (2010). Tissue Doppler echocardiography reveals distinct patterns of impaired myocardial velocities in different degrees of coronary artery disease. European Journal of Echocardiography. 11(6). 544–549. 23 indexed citations

16.

Hvelplund, Anders, S. Galatius, Mette Madsen, et al.. (2009). Women with acute coronary syndrome are less invasively examined and subsequently less treated than men. European Heart Journal. 31(6). 684–690. 113 indexed citations

17.

Pfisterer, Matthias, Osmund Bertel, Piero O. Bonetti, et al.. (2008). Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: Study protocol and design. American Heart Journal. 155(4). 609–614. 24 indexed citations

18.

Gustafsson, Finn, et al.. (2003). Hyperkalemia and impaired renal function during treatment with spironolactone in patients with congestive heart failure: Figures from a real world scenario. Journal of the American College of Cardiology. 41(6). 265–265. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact